CYP2A6 Effects on Subjective Reactions to Initial Smoking Attempt

被引:2
|
作者
Cannon, Dale S. [1 ]
Mermelstein, Robin J. [2 ,3 ]
Medina, Tait R. [4 ]
Pugach, Oksana [4 ]
Hedeker, Donald [5 ]
Weiss, Robert B. [6 ]
机构
[1] Univ Utah, Sch Med, Dept Psychiat, 650 Komas Dr,Suite 206, Salt Lake City, UT 84108 USA
[2] Univ Illinois, Inst Hlth Res, Chicago, IL USA
[3] Univ Illinois, Policy & Psychol Dept, Chicago, IL USA
[4] Univ Illinois, Inst Publ Hlth Res & Policy, Chicago, IL USA
[5] Univ Chicago, Dept Hlth Sci, Chicago, IL 60637 USA
[6] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84108 USA
基金
美国国家卫生研究院;
关键词
NICOTINE DEPENDENCE; TOBACCO DEPENDENCE; SMOKERS; ASSOCIATION; ADDICTION; BEHAVIOR; GENES; RISK; ADOLESCENTS; METABOLISM;
D O I
10.1093/ntr/ntv244
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: In very novice smokers, CYP2A6 genotypes that reduce nicotine metabolism to an intermediate rate may increase smoking risk, relative to both normal and slow rates. The present study examined the hypothesis that intermediate metabolism variants are associated with greater pleasurable effects of the initial smoking attempt than either normal or slow metabolism variants. Methods: Participants were novice smokers (N = 261, 65% female) of European descent. Predicted nicotine metabolic rate based on CYP2A6 diplotypes (CYP2A6 Diplotype Predicted Rate [CDPR]) was partitioned into Normal, Intermediate, and Slow categories using a metabolism metric. Subjective reactions to the initial smoking attempt were assessed by the Pleasurable Smoking Experiences (PSE) scale, which was collected within 3 years of the initial smoking attempt. The effect of CDPR on PSE was tested using a generalized linear model in which CDPR was dummy coded and Intermediate CDPR was the reference condition. Gender was included in the model as a control for higher PSE scores by males. Results: Lower PSE scores were associated with Normal CDPR, beta = -0.34, P =.008, and Slow CDPR, beta = -0.52, P =.001, relative to Intermediate CDPR. Conclusions: Intermediate CDPR-enhanced pleasurable effects of the initial smoking attempt relative to other CYP2A6 variants. This finding is consistent with the hypothesis that the risk effect of Intermediate CDPR on early smoking is a function of optimal pleasurable effects. Implications: This study supports our recent hypothesis that CYP2A6 diplotypes that encode intermediate nicotine metabolism rate are associated with enhanced pleasurable events following the initial smoking attempt, compared with diplotypes that encode either normal or slow metabolism. This hypothesis was offered to account for our unexpected previous finding of enhanced smoking risk in very novice smokers associated with intermediate metabolism rate. Our new finding encourages further investigation of time-dependent relations between CYP2A6 effects and smoking motives, and it encourages laboratory study of the mechanisms underlying the initial smoking enhancement in novice smokers associated with intermediate metabolism.
引用
收藏
页码:637 / 641
页数:5
相关论文
共 50 条
  • [21] Genetically variable CYP2A6 influences smoking behaviour.
    Pianezza, ML
    Sellers, EM
    Tyndale, RF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 171 - 171
  • [22] Lack of correlation between CYP2A6 genotype and smoking habits
    Schulz, TG
    Ruhnau, P
    Müller, M
    Bünger, J
    Elliehausen, HJ
    Hallier, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R168 - R168
  • [23] Association of smoking with cadmium induction of hepatic CYP2A6 in humans
    Satarug, Soisungwan
    Moore, Michael R.
    TOXICOLOGY LETTERS, 2006, 164 : S284 - S284
  • [24] Lack of correlation between CYP2A6 genotype and smoking habits
    Schulz, TG
    Ruhnau, P
    Hallier, E
    BIOLOGICAL REACTIVE INTERMEDIATES VI: CHEMICAL AND BIOLOGICAL MECHANISMS IN SUSCEPTIBILITY TO AND PREVENTION OF ENVIRONMENTAL DISEASES, 2001, 500 : 213 - 215
  • [25] CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians
    G M Vasconcelos
    C J Struchiner
    G Suarez-Kurtz
    The Pharmacogenomics Journal, 2005, 5 : 42 - 48
  • [26] Lack of correlation between CYP2A6 genotype and smoking habits
    Schulz, TG
    Ruhnau, P
    Müller, M
    Bünger, J
    Ellie-hausen, HJ
    Hallier, E
    TOXICOLOGY, 2001, 164 (1-3) : 150 - 151
  • [27] Smoking behavior and related cancers:: The role of CYP2A6 polymorphisms
    Nakajima, Miki
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2007, 9 (06) : 538 - 544
  • [28] CYP2A6 metabolism in the development of smoking behaviors in young adults
    Olfson, Emily
    Bloom, Joseph
    Bertelsen, Sarah
    Budde, John P.
    Breslau, Naomi
    Brooks, Andrew
    Culverhouse, Robert
    Chan, Grace
    Chen, Li-Shiun
    Chorlian, David
    Dick, Danielle M.
    Edenberg, Howard J.
    Hartz, Sarah
    Hatsukami, Dorothy
    Hesselbrock, Victor M.
    Johnson, Eric O.
    Kramer, John R.
    Kuperman, Samuel
    Meyers, Jacquelyn L.
    Nurnberger, John
    Porjesz, Bernice
    Saccone, Nancy L.
    Schuckit, Marc A.
    Stitzel, Jerry
    Tischfield, Jay A.
    Rice, John P.
    Goate, Alison
    Bierut, Laura J.
    ADDICTION BIOLOGY, 2018, 23 (01) : 437 - 447
  • [29] CYP2A6 Longitudinal Effects in Young Smokers
    Cannon, Dale S.
    Medina, Tait R.
    Mermelstein, Robin J.
    Hedeker, Donald
    Bakian, Amanda V.
    Coon, Hilary
    Cook, Edwin H.
    Hamil, Cindy
    Weiss, Robert B.
    NICOTINE & TOBACCO RESEARCH, 2016, 18 (02) : 196 - 203
  • [30] A pilot study characterizing two novel CYP2A6 alleles, CYP2A6*7 and CYP2A6*8, in vivo.
    Xu, C
    Rao, Y
    Xu, B
    Hoffmann, E
    Sellers, EM
    Tyndale, RF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P35 - P35